Enrollment Completed in SORAMIC Study of Sorafenib With SIR-Spheres to Treat Hepatocellular Carcinoma

March 29, 2016—Prof. Jens Ricke, MD, recently announced that the palliative cohort of the pan-European SORAMIC study has reached its enrollment target of 420 patients with unresectable primary liver cancer (hepatocellular carcinoma [HCC]). Prof. Ricke, who codirects the SORAMIC trial with Prof. Peter Malfertheiner, MD, is Professor of Radiology and Director of the Clinic for Radiology and…

Details